Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary endopoint is to determine whether ketoconazole/octreotide combination therapy, followed by octreotide monotherapy, is an effective treatment for Cushing's disease.
Critère d'inclusion
- Cushing's disease (which is caused by an ACTH producing pituitary adenoma)